Effect of gemcitabine on acute and late radiation toxicity of skin and underlying soft tissues to single-dose irradiation in a nude mice model

International Journal of Radiation Oncology Biology Physics

Volumn 53, Issue 1, 2002, Pages 197-205

  Classen, Johannes ^a   Paulsen, Frank ^a   Hehr, Thomas ^a   Bamberg, Michael ^a   Budach, Wilfried ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Fibrosis; Gemcitabine; Leg contracture; Radiotherapy; Skin contracture

Indexed keywords

BIOASSAY; CHEMOTHERAPY; IRRADIATION; RADIOTHERAPY; SKIN; TISSUE;

SKIN REACTIONS;

TOXICITY;

GEMCITABINE;

ARTICLE; CHEMOTHERAPY; CONTROLLED STUDY; DOSE RESPONSE; DOSE TIME EFFECT RELATION; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; RADIATION DOSE; SCORING SYSTEM; SKIN FIBROSIS; SKIN MANIFESTATION; SKIN TOXICITY; SOFT TISSUE; TOXICITY;

ANIMALS; CONNECTIVE TISSUE; DEOXYCYTIDINE; DOSE-RESPONSE RELATIONSHIP, RADIATION; FIBROSIS; MICE; MICE, NUDE; RADIATION-SENSITIZING AGENTS; SKIN; TIME FACTORS;

EID: 0036570253     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(02)02732-3     Document Type: Article

References (21)

1. Phase I studies with the novel nucleoside analog gemcitabine
2. Modulatory activity of 2′,2′-difluorodeoxycytidine on the phosphorylation and cytotoxicity of arabinosyl nucleosides
3. Enhancement of radiation-induced regrowth delay by gemcitabine in a human tumor xenograft model
4. Metabolism of 2′,2′-difluoro-2′-deoxycytidine, and radiation sensitization of human colon carcinoma cells
5. Maximizing therapeutic gain with gemcitabine and fractionated radiation
6. Radiation concurrent with gemcitabine for locally advanced head and neck cancer: A phase I trial and intracellular drug incorporation study
7. Gemzar (Gemcitabine) with thoracic radiotherapy: A phase II pilot study in chemonaive patients with advanced non-small cell lung cancer (NSCLC)
8. Effect of gemcitabine on the tolerance of the lung to single-dose irradiation in CH3 mice
9. Kinetics of mouse jejunum radiosensitization by 2′,2′-difluorodeoxycytidine (gemcitabine) and its relationship with pharmacodynamics of DNA synthesis inhibition and cell cycle redistribution in crypt cells
10. Radiosensitization produced in vivo by once- vs. twice weekly 2′-2′-difluoro-2′-deoxycytidine (gemcitabine)
11. A time-saving system for irradiations of experimental tumors
12. The effect of multiple small doses of x-rays on skin reactions in the mouse and a basic interpretation
13. Effect of fractionated radiation dose on skin contraction and skin reaction of Swiss mice
14. Leg contracture in mice: An assay of normal tissue response
15. The effect of 2′-2′difluorodeoxycytidine (dFdC, gemcitabine) on radiation-induced cell lethality in two human head and neck squamous carcinoma cell lines differing in intrinsic radiosensitivity
16. Alternating/concomitant gemcitabine (GEM), cisplatin (CDDP) and radiotheray (RT) in advanced squamous cell carcinoma of the head and neck (SCC-HN)
17. Radiation enhancement of gemcitabine in two human squamous cell carcinoma cell lines
18. Radiosensitizing of mouse sarcoma cells by fludarabine or gemcitabine is not mediated by an increased induction or a repair inhibition of DNA double strand breaks as measured by pulsed-field gel electrophoresis
19. Enhancement of tumor radioresponse in vivo by gemcitabine
20. Radiosensitization by gemcitabine
21. Phase I trial of twice-weekly gemcitabine and concurrent radiation in patients with advanced pancreatic cancer